Works matching DE "BLOOD coagulation factor VIII antibodies"
Results: 792
Immunohistochemistry in the evaluation of neovascularization in tumor xenografts.
- Published in:
- Biotechnic & Histochemistry, 2008, v. 83, n. 3/4, p. 179, doi. 10.1080/10520290802451085
- By:
- Publication type:
- Article
Gene therapy: Genie in a vector.
- Published in:
- Nature, 2014, v. 515, n. s7528, p. S160, doi. 10.1038/515S160a
- By:
- Publication type:
- Article
A 9-year-old patient with severe haemophilia A complicated by factor VIII inhibitor treated with emicizumab -- case report and literature review.
- Published in:
- Journal of Pre-Clinical & Clinical Research, 2024, v. 18, n. 2, p. 128, doi. 10.26444/jpccr/187549
- By:
- Publication type:
- Article
Imbalance between procoagulant factors and natural coagulation inhibitors contributes to hypercoagulability in the critically ill COVID-19 patient: clinical implications.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2020, v. 24, n. 17, p. 9161
- By:
- Publication type:
- Article
Hemophilia A subjects with an intron-22 gene inversion mutation show CD4<sup>+</sup> T-effector responses to multiple epitopes in FVIII.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1128641
- By:
- Publication type:
- Article
Modulating the microenvironment during FVIII uptake influences the nature of FVIII-peptides presented by antigen-presenting cells.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.975680
- By:
- Publication type:
- Article
Hemophilia A--Acquired During Coronary Artery Bypass Grafting.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
A SINE Insertion in F8 Gene Leads to Severe Form of Hemophilia A in a Family of Rhodesian Ridgebacks.
- Published in:
- Genes, 2021, v. 12, n. 2, p. 134, doi. 10.3390/genes12020134
- By:
- Publication type:
- Article
Patient satisfaction and acceptability of an on-demand and on-prophylaxis device for factor VIII delivery in patients with hemophilia A.
- Published in:
- Patient Preference & Adherence, 2019, v. 13, p. 233, doi. 10.2147/PPA.S175254
- By:
- Publication type:
- Article
Formation of antibodies to factor VIII in patients with hemophilia A who are treated with...
- Published in:
- Annals of Internal Medicine, 1996, v. 125, n. 4, p. 297, doi. 10.7326/0003-4819-125-4-199608150-00007
- By:
- Publication type:
- Article
Diagnosis and Management of Acquired Hemophilia A: Case Reports and a Literature Review.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
The availability of new drugs for hemophilia treatment.
- Published in:
- Expert Review of Clinical Pharmacology, 2020, v. 13, n. 7, p. 721, doi. 10.1080/17512433.2020.1776109
- By:
- Publication type:
- Article
How an engineered therapy could replace the need for potentially harmful plasma infusions.
- Published in:
- Expert Review of Clinical Pharmacology, 2019, v. 12, n. 4, p. 289, doi. 10.1080/17512433.2019.1588109
- By:
- Publication type:
- Article
Molecular genetics of hemophilia A: Clinical perspectives.
- Published in:
- Egyptian Journal of Medical Human Genetics, 2010, v. 11, n. 2, p. 105, doi. 10.1016/j.ejmhg.2010.10.005
- By:
- Publication type:
- Article
Why Does the Precautionary Principle Suffice for Blood Regulation?
- Published in:
- Pharmaceutical Medicine, 2021, v. 35, n. 5, p. 281, doi. 10.1007/s40290-021-00400-0
- By:
- Publication type:
- Article
From a bispecific monoclonal antibody to gene therapy: A new era in the treatment of hemophilia A.
- Published in:
- Biomedical Papers of the Medical Faculty of Palacky University in Olomouc, 2023, v. 167, n. 1, p. 1, doi. 10.5507/bp.2022.046
- By:
- Publication type:
- Article
Place of Emicizumab in the Management of Hemophilia A: Review Article.
- Published in:
- Egyptian Journal of Hospital Medicine, 2023, v. 91, p. 4535, doi. 10.21608/ejhm.2023.296759
- By:
- Publication type:
- Article
Special Issue "Development and Synthesis of Biologically Active Compounds".
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 7, p. 4015, doi. 10.3390/ijms25074015
- By:
- Publication type:
- Article
In Utero Cell Treatment of Hemophilia A Mice via Human Amniotic Fluid Mesenchymal Stromal Cell Engraftment.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 22, p. 16411, doi. 10.3390/ijms242216411
- By:
- Publication type:
- Article
Isolated Variable Domains of an Antibody Can Assemble on Blood Coagulation Factor VIII into a Functional Fv-like Complex.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 15, p. 8134, doi. 10.3390/ijms23158134
- By:
- Publication type:
- Article
Ectopic Expression of FVIII in HPCs and MSCs Derived from hiPSCs with Site-Specific Integration of ITGA2B Promoter-Driven BDDF8 Gene in Hemophilia A.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 2, p. 623, doi. 10.3390/ijms23020623
- By:
- Publication type:
- Article
A Foundational Study for Normal F8-Containing Mouse Models for the miRNA Regulation of Hemophilia A: Identification and Analysis of Mouse miRNAs that Downregulate the Murine F8 Gene.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 16, p. 5621, doi. 10.3390/ijms21165621
- By:
- Publication type:
- Article
The Last 50 years of Hemophilia Care: A Golden Era.
- Published in:
- Indian Pediatrics, 2024, v. 61, n. 5, p. 489, doi. 10.1007/s13312-024-3140-1
- By:
- Publication type:
- Article
Polymorphisms in the <i>F8</i> Gene and MHC-II Variants as Risk Factors for the Development of Inhibitory Anti-Factor VIII Antibodies during the Treatment of Hemophilia A: A Computational Assessment
- Published in:
- PLoS Computational Biology, 2013, v. 9, n. 5, p. 1, doi. 10.1371/journal.pcbi.1003066
- By:
- Publication type:
- Article
Assessment of ex vivo Pharmacodynamic Markers during Inhibition of Thrombosis by CI-1031 (ZK-807834), a Novel Direct Factor Xa Inhibitor.
- Published in:
- Pharmacology, 2002, v. 64, n. 2, p. 76, doi. 10.1159/000056154
- By:
- Publication type:
- Article
Laboratory Assessment of Factor VIII Inhibitors: When Is It Required? A Perspective Informed by Local Practice.
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 1, p. 13, doi. 10.3390/jcm14010013
- By:
- Publication type:
- Article
Surgery and Prophylaxis with Susoctocog-Alfa in Acquired Hemophilia: Case Series and Literature Review.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 14, p. 4590, doi. 10.3390/jcm12144590
- By:
- Publication type:
- Article
The use of recombinant activated factor VII in platelet-associated bleeding.
- Published in:
- Hematology, 2008, v. 13, n. 1, p. 41, doi. 10.1179/102453308X315816
- By:
- Publication type:
- Article
Pattern of factor VIII inhibitors in patients with hemophilia A in the north east of Iran.
- Published in:
- Hematology, 2006, v. 11, n. 3, p. 215, doi. 10.1080/10245330600667526
- By:
- Publication type:
- Article
Acquired hemophilia A.
- Published in:
- Hematology, 2006, v. 11, n. 2, p. 119, doi. 10.1080/10245330600574185
- By:
- Publication type:
- Article
Epidemiology, spectrum of clinical manifestations and diagnostic issue of acquired haemophilia: A case series.
- Published in:
- Malaysian Journal of Pathology, 2019, v. 41, n. 2, p. 185
- By:
- Publication type:
- Article
The spectrum of neutralizing and non-neutralizing anti-FVIII antibodies in a nationwide cohort of 788 persons with hemophilia A.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1355813
- By:
- Publication type:
- Article
Factor VIII antibody immune complexes modulate the humoral response to factor VIII in an epitope-dependent manner.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1233356
- By:
- Publication type:
- Article
Overview of the human pharmacokinetics of recombinant activated factor VII.
- Published in:
- British Journal of Clinical Pharmacology, 2008, v. 65, n. 1, p. 3, doi. 10.1111/j.1365-2125.2007.03030.x
- By:
- Publication type:
- Article
A Sparsely Vascularised Zone in the Cortex of the Bovine Ovary.
- Published in:
- Anatomia, Histologia, Embryologia: Journal of Veterinary Medicine Series C, 1998, v. 27, n. 3, p. 143, doi. 10.1111/j.1439-0264.1998.tb00171.x
- By:
- Publication type:
- Article
Liver-directed lentiviral gene therapy corrects hemophilia A mice and achieves normal-range factor VIII activity in non-human primates.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-30102-3
- By:
- Publication type:
- Article
Rituximab for Treatment of Hemophilia A with High-Responder Inhibitors.
- Published in:
- Iranian Journal of Pediatric Hematology & Oncology, 2017, v. 7, n. 4, p. 224
- By:
- Publication type:
- Article
An 89-Year-Old Man with COVID-19- Associated Coagulopathy Presenting with a Prolonged Partial Thromboplastin Time, Lupus Anticoagulant, and a High Titer of Factor VIII Inhibitor.
- Published in:
- American Journal of Case Reports, 2020, v. 21, p. 1, doi. 10.12659/AJCR.926728
- By:
- Publication type:
- Article
Utilization of Emicizumab in Acquired Factor VIII Deficiency.
- Published in:
- American Journal of Case Reports, 2020, v. 21, p. 1, doi. 10.12659/AJCR.922326
- By:
- Publication type:
- Article
Breakthrough bleeding episodes in pediatric severe hemophilia a patients with and without inhibitors receiving emicizumab prophylaxis: a single-center retrospective review.
- Published in:
- Pediatric Hematology & Oncology, 2022, v. 39, n. 5, p. 418, doi. 10.1080/08880018.2021.2004269
- By:
- Publication type:
- Article
Inflammatory and immune response genes: A genetic analysis of inhibitor development in Iranian hemophilia A patients.
- Published in:
- Pediatric Hematology & Oncology, 2019, v. 36, n. 1, p. 28, doi. 10.1080/08880018.2019.1585503
- By:
- Publication type:
- Article
Prominent Mutation of Intron 22 Inversion in Sporadic Hemophilia: Is It Worth the Antenatal Screening?
- Published in:
- Application of Clinical Genetics, 2022, v. 15, p. 49, doi. 10.2147/TACG.S363132
- By:
- Publication type:
- Article
Acquired hemophilia A in a Taiwanese patient with bullous pemphigoid.
- Published in:
- International Journal of Rheumatic Diseases, 2023, v. 26, n. 9, p. 1838, doi. 10.1111/1756-185X.14690
- By:
- Publication type:
- Article
Effective treatment of chemoresistant breast cancer in vitro and in vivo by a factor VII-targeted photodynamic therapy.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Factor VIII haplotypes in severe hemophilia A patients in India.
- Published in:
- 2013
- By:
- Publication type:
- Letter
Survivin: a unique target for tumor therapy.
- Published in:
- Cancer Cell International, 2016, v. 16, p. 1, doi. 10.1186/s12935-016-0326-1
- By:
- Publication type:
- Article
The Development of FVIII Inhibitors in Relation to IL10 Gene Polymorphism in Hemophilia A Egyptian Pediatric Patients.
- Published in:
- Fetal & Pediatric Pathology, 2017, v. 36, n. 3, p. 184, doi. 10.1080/15513815.2017.1281363
- By:
- Publication type:
- Article
Varicella as a trigger of atypical haemolytic uraemic syndrome associated with complement dysfunction: two cases.
- Published in:
- 2009
- By:
- Publication type:
- Case Study
Outcomes of Emicizumab in Acquired Hemophilia Patients: A Systematic Review.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2024, v. 30, p. 1, doi. 10.1177/10760296241298661
- By:
- Publication type:
- Article